DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Breast Cancer Dr. Padma Poddutoori, PG-Y3, I.M. Dr.Sohail Chaudhry, Attending Physician, Hemoncology.
Documents Breast Cancer Dr. Padma Poddutoori, PG-Y3, I.M. Dr.Sohail Chaudhry, Attending Physician,...

Slide 1Breast Cancer Dr. Padma Poddutoori, PG-Y3, I.M. Dr.Sohail Chaudhry, Attending Physician, Hemoncology. Slide 2 Clinical case presentation CC: lump in the left breast…

February 2010 Selected Zoonotic Diseases Conference Call
Business February 2010 Selected Zoonotic Diseases Conference Call

1.February 3, 2010 Selected Zoonotic DiseasesConference Call *Proposed *2. February 3, 2010 Selected Zoonotic DiseasesConference Call   Update on Dengue in the United States+…

February 2010 Selected Zoonotic Diseases Conference Call
Business February 2010 Selected Zoonotic Diseases Conference Call

1.February 3, 2010 Selected Zoonotic DiseasesConference Call *Proposed *2. February 3, 2010 Selected Zoonotic DiseasesConference Call   Update on Dengue in the United States+…

Reusability And Reusable Design
Education Reusability And Reusable Design

1.Reusability and Reusable Design Ben Clark - IT 80002. Reusability and Reusable DesignWhat is reusability? • The ability to use the same resource multiple times in multiple…

ER, PR and HER2 discordance between 1ry and recurrent breast cancer
Health & Medicine ER, PR and HER2 discordance between 1ry and recurrent breast cancer

Presented By Mohamed Mohamed Alhefny Evaluation of Discordance Rate of HER2, ER, PR Receptors Status between Primary Breast Cancer and Distant Metastasis or Locoregional…

Correlation of Her-2 neu over-expression with clinico pathological features of carcinoma breast
Health & Medicine Correlation of Her-2 neu over-expression with clinico pathological features of carcinoma breast

1. Correlation of Her-2 neu over-expression with clinico pathological features of carcinoma breast 2. a p o l l o m e d i c i n e 1 0 ( 2 0 1 3 ) 3 1 3 e3 1 7Available online…

Supplementary Figure 1. Supplementary Figure 2 All patients CharacteristicN% Median Age of patients 58 yrs ER Positive 40 69 Negative 18 31 PR Positive.
Documents Supplementary Figure 1. Supplementary Figure 2 All patients CharacteristicN% Median Age of patients....

Slide 1 Supplementary Figure 1 Slide 2 Supplementary Figure 2 Slide 3 All patients CharacteristicN% Median Age of patients 58 yrs ER Positive 40 69 Negative 18 31 PR Positive…

ONCOLOGY BOARD REVIEW. Most Common Solid Tumors TypeStagingPrimary RxAdjuvant RxSurveillance/ Screening Systemic RxMisc Breast Colorectal Lung (NSCL)
Documents ONCOLOGY BOARD REVIEW. Most Common Solid Tumors TypeStagingPrimary RxAdjuvant RxSurveillance/...

ONCOLOGY BOARD REVIEW Most Common Solid Tumors TNM Type Staging Primary Rx Adjuvant Rx Surveillance/Screening Systemic Rx Misc Breast Colorectal Lung (NSCL) Lung (SCLC) Prostate…

IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra.
Documents IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*,...

IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra Anatomia…

IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER
Documents IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER

IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra Anatomia…

Popular Categories
Relevant Tags